Atheric Pharmaceutical
Atheric Pharmaceutical, LLC was an American biopharmaceutical company based in Troy, Virginia.1) It was founded in February 2016 by Robert Malone, Jill Glasspool-Malone and Jeffrey DiFrancesco.2)
Atheric was focused on the “rapid development and commercialization of re-purposed drugs to prevent and treat Zika and other Flavivirus disease.”3)
Organization
Personnel
| Atheric Pharmaceutical - Team4) | ||
|---|---|---|
| Name | Position | Notes |
| Robert Malone | Chief Executive Officer, Chief Scientific Officer, Co-Founder | Co-inventor of DNA vaccines |
| Jill Glasspool-Malone | Vice President of Pre-Clinical Research and External Relations | University of California Davis, University of California San Diego |
| Patricia Hommel | Business Development | Center for Innovative Technology, Chesapeake Innovation Center (CIC) |
| Diego Mezzogiorno | - | World Bank, United Nations Development Programme (UNDP) |
| James Talton | Advisor | Alchem Laboratories, Nanotherapeutics |
External links
1)
Contact. Atheric Pharmaceutical. Retrieved June 6, 2017, from https://archive.ph/AUtWC
2)
Atheric Pharmaceutical LLC. Gust. Retrieved February 25, 2023, from https://archive.ph/DZhAm
3)
Atheric Pharmaceutical - Crunchbase Company Profile & Funding. Crunchbase. Retrieved February 25, 2023, from https://www.crunchbase.com/organization/atheric-pharmaceutical
4)
The Team. Atheric Pharmaceutical. Retrieved July 14, 2017, from https://archive.ph/7ATKO